Details of the Drug

General Information of Drug (ID: DM1ZK4W)

Drug Name
TRBC1
Indication
Disease Entry ICD 11 Status REF
Anaplastic large cell lymphoma 2A90.A Phase 1/2 [1]
Angioimmunoblastic T-cell Lymphoma 2A90.9 Phase 1/2 [1]
Non-hodgkin lymphoma 2B33.5 Phase 1/2 [1]
Peripheral T-cell lymphoma 2A90.C Phase 1/2 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D01MDX
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
T-cell receptor beta constant 1 (TRBC1) TT1DHW2 TRBC1_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03590574) Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma